Zhijun Liu

7PUBLICATIONS
7CO-AUTHORS
Cancer geneticsMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Sensor technology (incl. chemical aspects)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Apr 14, 2026
Suppression of Glucosylceramide Synthase Reverses Drug Resistance in Cancer Cells Harboring Homozygous p53 Mutants.

Md Saqline Mostaq, Mohammad N Amin, Amanda Raphael

|Nov 24, 2025
Suppression of Glucosylceramide Synthase Reverses Drug Resistance in Cancer Cells Harbor Homozygous p53 Mutants.

Md Saqline Mostaq, Mohammad N Amin, Amanda Raphael

|Jun 13, 2025
Glucosylceramide Synthase, a Key Enzyme in Sphingolipid Metabolism, Regulates Expression of Genes Accounting for Cancer Drug Resistance.

Md Saqline Mostaq, Lin Kang, Gauri A Patwardhan

|Oct 25, 2019
Ceramide-Rubusoside Nanomicelles, a Potential Therapeutic Approach to Target Cancers Carrying p53 Missense Mutations.

Sachin K Khiste, Zhijun Liu, Kartik R Roy

|Jun 09, 2017
Incorporation of Fluorescence Ceramide-Based HPLC Assay for Rapidly and Efficiently Assessing Glucosylceramide Synthase In Vivo.

Sachin K Khiste, Salman B Hosain, Yixuan Dong

Pageof 2

Frequent Collaborators

2 joint publications

Kartik R Roy

2 joint publications

Sami Nazzal

2 joint publications

Ronald A Hill

2 joint publications

Md Saqline Mostaq